Lana Langendries
Leuven, VLG 3000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Design, synthesis, and lead optimization of piperazinyl-pyrimidine analogues as potent small molecules targeting the viral capping machinery of Chikungunya virus.
Journal: European journal of medicinal chemistry
Published: September 12, 2023
Perturbation of Alphavirus and Flavivirus Infectivity by Components of the Bacterial Cell Wall.
Journal: Journal of virology
Published: February 02, 2022
An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models.
Journal: Science translational medicine
Published: October 05, 2021
The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model.
Journal: EBioMedicine
Published: June 15, 2021
Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial.
Journal: EBioMedicine
Published: November 25, 2020
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 10, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026